Resident doctors, PhD students, young researchers, and masters students coordinated the CoEHAR annual meeting dedicated to the World No Tobacco Day 2024, sharing experiences from their own social contexts, including…
The global action to end smoking grantmaking will continue to focus on advancing health and science research for cutting-edge smoking cessation and reduced-risk solutions, with a particular focus on marginalized communities and low- and middle-income countries where smoking is most widespread.
Catania, April 29, 2024 - This morning, as part of the April graduation session of the Bachelor's Degree in Biotechnology at the University of Catania, four more theses on the…
But how much would harm reduction and the reduction of smoking-related diseases affect international health policy strategies? Would there be fewer hospital admissions without conventional cigarette smoke? The answer will be provided by questionnaires administered to over 3000 hospitalized patients whose smoking habits and potential use of non-combustion products will be analyzed to assess the causes of hospital admission and the subsequent outcomes of the diseases identified.
Currently engaged in her internship at the laboratory of Prof. Massimo Caruso, co-project leader of the Replica project, Chiara Giardina, thanks to the work conducted in the laboratories of CoEHAR in Catania, managed to participate in and obtain the KAC scholarship.
Dr. Nikolina Kastratovic of the Faculty of Medical Sciences at the University of Kragujevac, Serbia, was honored with the award for her outstanding project on the immunomodulatory effects of combustible and electronic cigarettes on human cells.
The Royal College of Physicians has assessed the available evidence on the use of e-cigarettes, from health effects to the issue of youth vaping, publishing a report with over 50 recommendations. It concluded that e-cigarettes represent a valuable aid in smoking cessation, but that much more can and should be done to reduce their appeal, availability and affordability to people who do not smoke, including children and young people, and reduce environmental harms.
According to the studies, “CoEHAR research in patients with COPD patients, asthma, high blood pressure, schizophrenia show clear benefits with objective evidence for harm reversal after switching from smoking.. and also showed that lung function and respiratory symptoms and muco-ciliary clearance improve after switching from smoking to vaping”.
The MAGNIFICAT study, strongly advocated by Prof. Riccardo Polosa, will evaluate the effects of the combined use of conventional cigarettes and electronic cigarettes on human health, quantifying this impact by collecting samples, researching and describing the core of different levels of dual use on exposure to toxic substances and harm reduction, and using specific biomarkers, clinical endpoints, and behavioral correlations
The data from these works as a whole can be used to assess the impact in terms of risk/benefit ratio of the regular use of combustion-free products, assisting the efforts of public health authorities in encouraging smokers to quit, especially those who perceive their smoke-damaged smile as a barrier to personal health or work and social relationships.
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.